Scholar Rock Holding Corp (SRRK) stock
SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$48.13−2.24 (-4.45%)
Close on Nov 20, 2026Market cap $5.86BP/E –Yield –
Scholar Rock free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Scholar Rock's free cash flow for the twelve months ending Jun 30, 2026 was -$297.01M. For fiscal 2025 it was -$300.64M. The highest annual figure on record is $23.08M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$300.64M | – |
| FY2024 | Dec 31, 2024 | -$201.05M | – |
| FY2023 | Dec 31, 2023 | -$145.30M | – |
| FY2022 | Dec 31, 2022 | -$133.76M | – |
| FY2021 | Dec 31, 2021 | -$132.04M | – |
| FY2020 | Dec 31, 2020 | -$64.36M | – |
| FY2019 | Dec 31, 2019 | -$66.23M | -387.0% |
| FY2018 | Dec 31, 2018 | $23.08M | – |
| FY2017 | Dec 31, 2017 | -$22.10M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$70.31M | – |
| Q1 FY2026 | Mar 31, 2026 | -$82.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$75.53M | – |
| Q3 FY2025 | Sep 30, 2025 | -$69.01M | – |
| Q2 FY2025 | Jun 30, 2025 | -$77.16M | – |
| Q1 FY2025 | Mar 31, 2025 | -$78.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$49.54M | – |
| Q3 FY2024 | Sep 30, 2024 | -$52.49M | – |
| Q2 FY2024 | Jun 30, 2024 | -$49.22M | – |
| Q1 FY2024 | Mar 31, 2024 | -$49.81M | – |
| Q4 FY2023 | Dec 31, 2023 | -$37.35M | – |
| Q3 FY2023 | Sep 30, 2023 | -$32.27M | – |
| Q2 FY2023 | Jun 30, 2023 | -$32.59M | – |
| Q1 FY2023 | Mar 31, 2023 | -$43.08M | – |
| Q4 FY2022 | Dec 31, 2022 | -$29.02M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.51M | – |
| Q2 FY2022 | Jun 30, 2022 | -$35.22M | – |
| Q1 FY2022 | Mar 31, 2022 | -$43.01M | – |
| Q4 FY2021 | Dec 31, 2021 | -$33.00M | – |
| Q3 FY2021 | Sep 30, 2021 | -$37.39M | – |
| Q2 FY2021 | Jun 30, 2021 | -$32.80M | – |
| Q1 FY2021 | Mar 31, 2021 | -$28.86M | -1289.0% |
| Q4 FY2020 | Dec 31, 2020 | -$21.66M | – |
| Q3 FY2020 | Sep 30, 2020 | -$25.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$19.90M | – |
| Q1 FY2020 | Mar 31, 2020 | $2.43M | – |
| Q4 FY2019 | Dec 31, 2019 | -$17.54M | -132.2% |
| Q3 FY2019 | Sep 30, 2019 | -$15.48M | – |
| Q2 FY2019 | Jun 30, 2019 | -$17.00M | – |
| Q1 FY2019 | Mar 31, 2019 | -$16.21M | – |
| Q4 FY2018 | Dec 31, 2018 | $54.39M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.61M | – |
| Q2 FY2018 | Jun 30, 2018 | -$11.64M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.06M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.17M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.78M | – |
See a number that looks wrong?